Answers are grounded in this paper and cite their sources.
Systematic review evaluates T2DM progression from GDM, suggesting targeted approaches for high-risk women.
This systematic review and meta-analysis of 15 contemporary cohort studies (2020-2026) evaluates the progression from gestational diabetes mellitus (GDM) to type 2 diabetes (T2DM). Screening 1,809 records, the study identified a significant pooled T2DM incidence of 9.0% (ES: 0.09; 95% CI, 0.04-0.13), with an adjusted estimate of 6.9% after addressing publication bias. Statistical consistency was high across all strata (I2 = 0%), indicating a universal metabolic phenomenon. Key clinical determinants significantly increasing T2DM risk included abnormal gestational OGTT results (ES: 4.28), maternal BMI > 25 kg/m2 (ES: 2.58), insulin requirement during pregnancy (ES: 2.21), and positive family history (ES: 2.00). The findings underscore that GDM serves as a critical window for future health. Healthcare systems must move beyond generalized advice to prioritize high-risk phenotypes, particularly women with obesity or severe gestational hyperglycemia. Integrating structured, risk-stratified postpartum surveillance and lifestyle interventions within the first year after delivery is essential to mitigate the long-term global burden of T2DM. This evidence advocates for standardized, globally consistent screening protocols to bridge the current gap in postpartum compliance and improve maternal metabolic outcomes.
No takes yet. Share an insight, caveat, or question.
Derse et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: